EU Clears Claros Diagnostics' POC PSA Immunoassay System

The company is currently conducting clinical trials of the quantitative immunoassay , which has a 15-minute run-time, in order eventually submit it with the FDA.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.